The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,274.00
Bid: 1,268.00
Ask: 1,276.00
Change: 6.00 (0.47%)
Spread: 8.00 (0.631%)
Open: 1,298.00
High: 1,298.00
Low: 1,242.00
Prev. Close: 1,268.00
VCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Victrex signs up to SBTi

21 Oct 2021 07:00

RNS Number : 7161P
Victrex PLC
21 October 2021
 
 

 

 

21 October 2021

Victrex plc

Victrex signs up to Science Based Target initiative (SBTi) as part of 2030 net zero goal

Victrex plc, an innovative world leader in high performance polymer solutions, delivering sustainable products which support CO2 reduction and bring environmental and societal benefit, has today announced its commitment to the Science Based Target initiative (SBTi), in addition to its 2030 carbon net zero goal1.

As part of its commitment to SBTi, Victrex has joined the Business Ambition for 1.5°C campaign - the world's largest and fastest-growing group of companies - that are aligning with 1.5°C and helping to halve global emissions by 2030.

Victrex's commitment follows on from its enhanced ESG (Environmental, Social & Governance) strategy launched in 2020, which includes its 2030 net zero goal and targets relating to minimising use of resources including energy, water and waste. Its ESG goals also include increasing the proportion of sustainable products as a percentage of its portfolio, and enhancing its programme on diversity & inclusion, and social responsibility.

Jakob Sigurdsson, Chief Executive of Victrex, said: "This is further evidence of Victrex's strong and long-term ESG commitment and the positive impact we are seeking to make to the environment and society."

 

"Our commitment to a science-based target for emissions is in line with climate science and also builds on the role our materials have played over many years in helping to bring environmental & societal benefit in a number of end markets. This includes supporting light-weighting and CO2 reduction in Aerospace & Automotive, and clinical benefit in Medical. We continue to further enhance our ESG strategy and expect to set out additional goals in our 2021 Annual Report."

 

Victrex recently received a Gold sustainability rating from EcoVadis, one of the world's leading sustainability rating agencies.

 

A full list of companies involved in SBTi can be found at sciencebasedtargets.org.

 

 

Notes:

 

1. Victrex's 2030 carbon net zero goal, launched in 2020, focuses on its Scope 1 & 2 emissions. As part of its commitment to SBTi, a science-based target will also include reporting on Scope 3 emission segments.

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications +44 (0) 1253 898121

+44 (0) 7809 595831

Jakob Sigurdsson, Chief Executive +44 (0) 1253 897700

Richard Armitage, Chief Financial Officer +44 (0) 1253 897700

 

 

 

 

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our sustainable materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 40 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, provide environmental and societal benefit for customers and drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEBLFLFBLFFBD
Date   Source Headline
17th Aug 201811:31 amRNSDirector/PDMR Shareholding
31st Jul 201810:56 amRNSTotal Voting Rights
27th Jul 20184:01 pmRNSHolding(s) in Company
25th Jul 201811:16 amRNSDirector/PDMR Shareholding
25th Jul 20187:00 amRNSInterim Management Statement
17th Jul 201812:47 pmRNSDirector/PDMR Shareholding
29th Jun 20189:26 amRNSTotal Voting Rights
19th Jun 20183:25 pmRNSDirector/PDMR Shareholding
1st Jun 20189:04 amRNSBlock listing Interim Review
31st May 20181:29 pmRNSTotal Voting Rights
17th May 20182:37 pmRNSDirector/PDMR Shareholding
16th May 20183:47 pmRNSDirector/PDMR Shareholding
14th May 20187:01 amRNSDirectorate Change
14th May 20187:00 amRNSHalf-year Report
1st May 201811:42 amRNSTotal Voting Rights
30th Apr 201811:40 amRNSAdditional Listing
17th Apr 20184:28 pmRNSDirector/PDMR Shareholding
28th Mar 201810:00 amRNSGroup Financial Director Update
19th Mar 20183:13 pmRNSDirector/PDMR Shareholding
1st Mar 20182:22 pmRNSTotal Voting Rights
19th Feb 20184:30 pmRNSDirector/PDMR Shareholding
12th Feb 201810:32 amRNSDirectorate Change
12th Feb 201810:30 amRNSDirectorate Change
9th Feb 201811:50 amRNSResult of AGM
9th Feb 201811:24 amRNSDirector/PDMR Shareholding
9th Feb 20187:00 amRNSAGM & Q1 IMS
7th Feb 20184:16 pmRNSHolding(s) in Company
6th Feb 20181:44 pmRNSDirectorate Change
1st Feb 201812:13 pmRNSTotal Voting Rights
25th Jan 20189:49 amRNSHolding(s) in Company
17th Jan 20184:25 pmRNSDirector/PDMR Shareholding
4th Jan 201812:06 pmRNSNomination for election of Non-executive Directors
4th Jan 201812:00 pmRNSAnnual Financial Report
29th Dec 201710:00 amRNSTotal Voting Rights
19th Dec 20174:24 pmRNSDirector/PDMR Shareholding
18th Dec 201710:08 amRNSDirector/PDMR Shareholding
8th Dec 20171:19 pmRNSDirector/PDMR Shareholding
5th Dec 201711:39 amRNSDirector/PDMR Shareholding
5th Dec 20177:01 amRNSDirectorate Change
5th Dec 20177:00 amRNSFinal Results
1st Dec 201712:51 pmRNSBlock listing Interim Review
30th Nov 20171:41 pmRNSTotal Voting Rights
27th Nov 201711:20 amRNSAdditional Listing
17th Nov 20173:57 pmRNSDirector/PDMR Shareholding
31st Oct 20179:41 amRNSTotal Voting Rights
17th Oct 20173:29 pmRNSDirector/PDMR Shareholding
29th Sep 201710:31 amRNSTotal Voting Rights
19th Sep 20172:59 pmRNSDirector/PDMR Shareholding
4th Sep 20177:01 amRNSCEO-designate update
4th Sep 20177:00 amRNSReduction in effective tax rate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.